Parsey Merdad
SEC CIK 1792150 · EDGAR
BoughtSold
Most active insiders at ARDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RAAB MICHAEL | Pres, CEO, Dir | — | $2.57M |
| 2 | MOTT DAVID M | Dir | $1.95M | — |
| 3 | Williams Laura A | See Remarks | — | $1.01M |
| 4 | Foster Eric Duane | Chief Commercial Off | — | $176.4K |
| 5 | Kelliher Mike | See Remarks | — | $162.3K |
| 6 | Reilly Joseph James | See Remarks | — | $129.3K |
| 7 | Bishop John E | See Remarks | — | $109.2K |
| 8 | Brady James Parker | CHRO | — | $84.8K |
| 9 | GRAMMER ELIZABETH A | See Remarks | — | $33.2K |
| 10 | Hohenleitner Susan | CFO | — | $27.0K |
| 13 | Parsey Merdad | Dir | — | — |
Transactions 57
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 17:14 | 2026-06-16 | ARDX | ARDELYX, INC. | Parsey Merdad | Dir | A - Grant | $0.00 | +26.5K | 83.7K | +46% | $0 |
| 2025-06-23 | 2025-06-18 | ARDX | ARDELYX, INC. | Parsey Merdad | Dir | A - Grant | $0.00 | +15.2K | 57.3K | +36% | $0 | |
| D | 2025-05-14 | 2025-04-28 | ARDX | ARDELYX, INC. | Parsey Merdad | Dir | A - Grant | $0.00 | +42.1K | 42.1K | New | $0 |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $92.34 | -1,771 | 82.8K | -2% | -$163.5K |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +3,820 | 84.6K | +5% | — |
| DM | 2024-11-29 | 2024-11-27 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale+OE | $91.92 | -164.2K | 99.6K | -62% | -$15.09M |
| DM | 2024-11-29 | 2024-11-27 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | $62.44 | +145.4K | 156.9K | +1,267% | +$9.08M |
| DM | 2024-11-07 | 2024-11-06 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale+OE | $91.50 | -25.6K | 99.6K | -20% | -$2.34M |
| D | 2024-11-07 | 2024-11-06 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | $57.92 | +25.0K | 125.2K | +25% | +$1.45M |
| 2024-10-02 | 2024-10-01 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $83.83 | -2,000 | 100.2K | -2% | -$167.7K | |
| D | 2024-09-13 | 2024-09-12 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale+OE | $84.50 | -21.2K | 102.2K | -17% | -$1.80M |
| D | 2024-09-13 | 2024-09-12 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | $57.92 | +25.0K | 123.4K | +25% | +$1.45M |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $81.44 | -1,766 | 98.4K | -2% | -$143.8K |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +3,821 | 100.2K | +4% | — |
| 2024-07-01 | 2024-07-01 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $68.63 | -2,000 | 96.4K | -2% | -$137.3K | |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +3,820 | 100.1K | +4% | — |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $65.25 | -1,744 | 98.4K | -2% | -$113.8K |
| 2024-04-02 | 2024-04-01 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $72.96 | -2,000 | 96.3K | -2% | -$145.9K | |
| DM | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +10.4K | 103.1K | +11% | — |
| D | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $75.12 | -4,803 | 98.3K | -5% | -$360.8K |
| M | 2024-02-29 | 2024-02-28+ | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $72.83 | -10.2K | 92.7K | -10% | -$745.0K |
| M | 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | A - Grant | $0.00 | +76.9K | 126.3K | +155% | $0 |
| 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $78.26 | -23.7K | 102.6K | -19% | -$1.86M | |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +2,779 | 72.9K | +4% | — |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $79.02 | -1,269 | 71.6K | -2% | -$100.3K |
| 2023-09-13 | 2023-09-12 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $76.99 | -1,501 | 70.1K | -2% | -$115.6K | |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +2,779 | 72.9K | +4% | — |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $76.00 | -1,278 | 71.6K | -2% | -$97.1K |
| D | 2023-07-20 | 2023-07-18 | SGMT | Sagimet Biosciences Inc. | Parsey Merdad | Dir | C - Cnv Deriv | — | +4,117 | 12.8K | +47% | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Sagimet Biosciences Inc. | Parsey Merdad | Dir | A - Grant | — | +8,677 | 8,677 | New | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Sagimet Biosciences Inc. | Parsey Merdad | Dir | D - Sale to Iss | — | -8,677 | 0 | -100% | — |
| 2023-06-14 | 2023-06-13 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $76.90 | -1,485 | 29.4K | -5% | -$114.2K | |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +2,779 | 32.2K | +9% | — |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $78.12 | -1,294 | 30.9K | -4% | -$101.1K |
| 2023-03-14 | 2023-03-13 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $78.99 | -6,126 | 70.1K | -8% | -$483.9K | |
| DM | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +11.5K | 81.6K | +16% | — |
| D | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $79.50 | -5,328 | 76.3K | -7% | -$423.6K |
| 2023-03-02 | 2023-03-01 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $79.96 | -13.0K | 70.1K | -16% | -$1.04M | |
| 2023-02-23 | 2023-02-15 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | A - Grant | $56.38 | +376 | 83.1K | +0.5% | +$21.2K | |
| 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $84.02 | -17.7K | 82.7K | -18% | -$1.49M | |
| M | 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | A - Grant | $0.00 | +73.4K | 56.8K | New | $0 |
| 2023-01-03 | 2022-12-30 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | S - Sale | $85.33 | -553 | 45.6K | -1% | -$47.2K | |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $87.97 | -486 | 46.1K | -1% | -$42.8K |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +1,039 | 46.6K | +2% | — |
| D | 2022-11-14 | 2022-11-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +5,099 | 47.8K | +12% | — |
| D | 2022-11-14 | 2022-11-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $82.60 | -2,268 | 45.6K | -5% | -$187.3K |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +1,039 | 43.2K | +2% | — |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $65.28 | -481 | 42.7K | -1% | -$31.4K |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $60.74 | -485 | 42.2K | -1% | -$29.5K |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +1,039 | 42.7K | +2% | — |
| 2022-04-13 | 2022-02-15 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | A - Grant | $52.13 | +348 | 41.6K | +0.8% | +$18.1K | |
| DM | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +7,612 | 44.8K | +20% | — |
| D | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $57.92 | -3,505 | 41.3K | -8% | -$203.0K |
| 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | A - Grant | $0.00 | +20.3K | 37.2K | +120% | $0 | |
| D | 2021-11-12 | 2021-11-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | M - OptEx | — | +5,100 | 19.2K | +36% | — |
| D | 2021-11-12 | 2021-11-10 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | F - Tax | $67.32 | -2,320 | 16.9K | -12% | -$156.2K |
| 2021-08-24 | 2021-08-15 | GILD | Gilead Sciences | Parsey Merdad | Chief Medical Off | A - Grant | $55.08 | +1 | 14.1K | +0.0% | +$55.08 |
Purchase Sale Sale after option exercise All abbreviations